OABI OmniAb, Inc.
$5.40▲ +2.27%
Healthcare
Other
Volume 168.2K
Avg Volume (10D) 1.41M
Key Metrics & Fundamentals
Market Cap
$785.11M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.30 - 5.43
% vs 50 MA
14.36%
% vs 200 MA
97.75%
RSI-14
63.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.25
Free Cash Flow
$2.57M
Gross Rev
$13.42M
Gross Profit
$12.81M
EBITDA
-$2.42M
COGS
$610,000
Operating Exp
$19.44M
Operating Income
-$6.64M
EBIT
-$6.64M
Pretax Income
-$6.21M
Net Income
-$5.86M
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
Earnings To Watch: OmniAb Inc (OABI) Q3 2026 -- GF Value Sees 40% Downside
GuruFocus.com · Oct 29, 2026 10:08 AM ET
OmniAb to Participate in Upcoming Investor Conferences in November
Business Wire · Oct 26, 2026 4:05 PM ET
OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conference
MarketBeat · Oct 25, 2026 12:02 AM ET
OmniAb to Report Third Quarter 2026 Financial Results on October 30
Business Wire · Oct 14, 2026 4:05 PM ET
OmniAb Investor Day Spotlights Royalty Pipeline, OmniTides Launch and xPloration Growth
MarketBeat · Oct 7, 2026 1:02 PM ET
All You Need to Know About OmniAb, Inc. (OABI) Rating Upgrade to Buy
Zacks · Oct 6, 2026 11:00 AM ET
OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day
Business Wire · Oct 6, 2026 8:00 AM ET
OmniAb to Host Investor & Analyst Day on October 6, 2026
Business Wire · Sep 14, 2026 8:00 AM ET
Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI?
Insider Monkey · Aug 28, 2026 4:02 PM ET
VERAXA Biotech (VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology
NewMediaWire · Aug 28, 2026 3:00 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See OABI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.